Grant: Planning and Dissemination Grant - Institute Community Support
University of Toronto
$10,000.00
Building a platform for advancing Canadian science in lymphoma: A strategic planning workshop of the Canadian Lymphoma Consortium (CLyC)
FY 2022-23
Summary
Despite the increasing number of Canadians affected by a diagnosis lymphoma, research advances from a Canadian perspective have been constrained by fragmentation of efforts across the country. Such gaps can be addressed through networks of investigators that coordinate research operations, resources, and expertise, thereby enhancing meaningful collaboration and reducing delays in discovery and knowledge translation. In Spring 2022, we created the Canadian Lymphoma Consortium (CLyC). With several studies ongoing and commitments from interdisciplinary investigators from 17 centres across the country, we are well positioned to accelerate Canadian contributions to basic and clinical research in lymphoma. In December 2023, we will convene our investigators for an in-person workshop to establish the strategic plan for this consortium. The half-day workshop will be held in December 2023 at an exact date and location that corresponds with the 65th American Society of Hematology (ASH) Annual Meeting & Exposition, the premier event in malignant and non-malignant hematology. Participants in the workshop will include CLyC investigators, collaborators, and patient partners, as well as special guests (e.g., content experts). The workshop, led by experienced facilitators, will emphasize solution-focused thinking and active collaboration between participants using breakout groups and exercises with application to use-case scenarios. The end goal will be the co-creation of strategic priorities for the consortium, which will directly guide decision-making related to our research activities in the short and long term. The active engagement of patients, clinicians, scientists, and advocacy groups from across Canada will ensure the national relevance of our work and expands the potential for impacts to clinical practice and policy decision making across the country.
Department
Program
Planning and Dissemination Grant - Institute Community Support
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
468186
Name
Mayo Samantha
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Planning and Dissemination - ICR
Projecttitle
Building a platform for advancing Canadian science in lymphoma: A strategic planning workshop of the Canadian Lymphoma Consortium (CLyC)
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Toronto
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Lymphoma; Research Consortium; Strategic Planning
Abstract
Despite the increasing number of Canadians affected by a diagnosis lymphoma, research advances from a Canadian perspective have been constrained by fragmentation of efforts across the country. Such gaps can be addressed through networks of investigators that coordinate research operations, resources, and expertise, thereby enhancing meaningful collaboration and reducing delays in discovery and knowledge translation. In Spring 2022, we created the Canadian Lymphoma Consortium (CLyC). With several studies ongoing and commitments from interdisciplinary investigators from 17 centres across the country, we are well positioned to accelerate Canadian contributions to basic and clinical research in lymphoma. In December 2023, we will convene our investigators for an in-person workshop to establish the strategic plan for this consortium. The half-day workshop will be held in December 2023 at an exact date and location that corresponds with the 65th American Society of Hematology (ASH) Annual Meeting & Exposition, the premier event in malignant and non-malignant hematology. Participants in the workshop will include CLyC investigators, collaborators, and patient partners, as well as special guests (e.g., content experts). The workshop, led by experienced facilitators, will emphasize solution-focused thinking and active collaboration between participants using breakout groups and exercises with application to use-case scenarios. The end goal will be the co-creation of strategic priorities for the consortium, which will directly guide decision-making related to our research activities in the short and long term. The active engagement of patients, clinicians, scientists, and advocacy groups from across Canada will ensure the national relevance of our work and expands the potential for impacts to clinical practice and policy decision making across the country.
Competitiondate
202207
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mayo, Samantha; Kuruvilla, John G
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Cancer Research~ $10,000~ $0~